Consumer & Prescriber Grant Program

The Consumer & Prescriber Grant Program (also going by other names, including Attorney General Prescriber Grant Program) was a grant program established with fines paid by Pfizer in the Franklin v. Parke-Davis trial for False Claims Act violations relating to off-label use of gabapentin.[1][2]

Grant recipients

There were 24 original grant recipients.

Oregon State University[3]
"Education about Heavily Marketed Drugs"[4]
PharmedOut[5]
Federation of State Medical Boards[6]
Robert Larner College of Medicine[7]
The Pew Charitable Trusts[8]
American Medical Association[9]

References

Rutkow, Lainie; Teret, Stephen (October 2010). "The Potential for State Attorneys General to Promote the Public's Health: Theory, Evidence, and Practice". Robert Wood Johnson Foundation Public Health Law Research Program, via FOLIO.
Price, DW; Raebel, MA; Conner, DA; Wright, LA (2008). "Prescribers' and Organizational Leaders' Preferences for Education about Heavily Marketed Drugs". The Permanente Journal. 12 (2): 28–35. doi:10.7812/tpp/07-106. PMC 3042287. PMID 21364809.
"Attorney Generals' Prescriber and Consumer Education Grant". College of Pharmacy. 4 October 2011.
Price, DW; Raebel, MA; Conner, DA; Wright, LA (2008). "Prescribers' and Organizational Leaders' Preferences for Education about Heavily Marketed Drugs". The Permanente Journal. 12 (2): 28–35. doi:10.7812/tpp/07-106. PMC 3042287. PMID 21364809.
Elliott, Carl (22 May 2012). "Pharmed Out: an Interview With Adriane Fugh-Berman". The Chronicle of Higher Education Blogs: Brainstorm.
"Federation of State Medical Boards". www.fsmb.org. Archived from the original on 2016-05-20. Retrieved 2017-06-21.
Vermont, University of (14 April 2006). "University Communications : University of Vermont". www.uvm.edu.
Nachbur, Jennifer (May 21, 2013). "Advancing Integrity in Medical Education". www.pewtrusts.org. The Pew Charitable Trusts.
Krautkramer, Christian J. (June 2006). "Neurontin and off-label marketing". AMA Journal of Ethics. 8 (6): 397–402. doi:10.1001/virtualmentor.2006.8.6.hlaw1-0606. PMID 23234671.

External links

Official website archival copy from March 2011. The website existed from 2008-2011.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[1] Rutkow, Lainie; Teret, Stephen (October 2010). "The Potential for State Attorneys General to Promote the Public's Health: Theory, Evidence, and Practice". Robert Wood Johnson Foundation Public Health Law Research Program, via FOLIO.

[2] Price, DW; Raebel, MA; Conner, DA; Wright, LA (2008). "Prescribers' and Organizational Leaders' Preferences for Education about Heavily Marketed Drugs". The Permanente Journal. 12 (2): 28–35. doi:10.7812/tpp/07-106. PMC 3042287. PMID 21364809.

[3] "Attorney Generals' Prescriber and Consumer Education Grant". College of Pharmacy. 4 October 2011.

[4] Price, DW; Raebel, MA; Conner, DA; Wright, LA (2008). "Prescribers' and Organizational Leaders' Preferences for Education about Heavily Marketed Drugs". The Permanente Journal. 12 (2): 28–35. doi:10.7812/tpp/07-106. PMC 3042287. PMID 21364809.

[5] Elliott, Carl (22 May 2012). "Pharmed Out: an Interview With Adriane Fugh-Berman". The Chronicle of Higher Education Blogs: Brainstorm.

[6] "Federation of State Medical Boards". www.fsmb.org. Archived from the original on 2016-05-20. Retrieved 2017-06-21.

[7] Vermont, University of (14 April 2006). "University Communications : University of Vermont". www.uvm.edu.

[8] Nachbur, Jennifer (May 21, 2013). "Advancing Integrity in Medical Education". www.pewtrusts.org. The Pew Charitable Trusts.

[9] Krautkramer, Christian J. (June 2006). "Neurontin and off-label marketing". AMA Journal of Ethics. 8 (6): 397–402. doi:10.1001/virtualmentor.2006.8.6.hlaw1-0606. PMID 23234671.